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ABSTRACT
We present the relational database EDULISS
(EDinburgh University Ligand Selection System),
which stores structural, physicochemical and
pharmacophoric properties of small molecules.
The database comprises a collection of over
4 million commercially available compounds from
28 different suppliers. A user-friendly web-based
interface for EDULISS (available at http://eduliss
.bch.ed.ac.uk/) has been established providing a
number of data-mining possibilities. For each
compound a single 3D conformer is stored along
with over 1600 calculated descriptor values
(molecular properties). A very efficient method for
unique compound recognition, especially for a
large scale database, is demonstrated by making
use of small subgroups of the descriptors. Many of
the shape and distance descriptors are held as
pre-calculated bit strings permitting fast and
efficient similarity and pharmacophore searches
which can be used to identify families of related
compounds for biological testing. Two ligand
searching applications are given to demonstrate
how EDULISS can be used to extract families of
molecules with selected structural and biophysical
features.
INTRODUCTION
The high throughput screening regimes of the past 20 years
led by big pharma and more recently developed by
screening centres through the Molecular Libraries
Roadmap program are providing increasing amounts of
publicly available biological information. The bioassay
and compound databases in PubChem (1) contain
information on over 25 million structures and on over 60
million data points from thousands of assays. Smaller but
well annotated databases like ChEMBLdb with over
500000 entries provide information on the properties and
activities of drug-like molecules and their targets (2). This
explosion of data linking compounds to biological activity
should provide a means for predicting new biological
effects for large numbers of classes of small drug-like
molecules using bioinformatic and database mining
approaches (3).
In order to test such in silico predictions it is important
to have databases of available compounds. It is only
relatively recently that searchable interactive small
molecule databases have become available to non-
commercial research groups. One such resource is
ChemDB (4), a searchable chemical database containing
nearly 5 million small molecules with their stereoisomers.
Interactive databases like ZINC (5) provide large and well
annotated collections with some searching capacity. Such
databases can contain a variety of structurally related
information stored as SMILES strings, InChI or
Daylight ﬁngerprints (6). 3D coordinates may also be
used as input for structure-based virtual screening (7–9)
or pharmacophore searching (10). The idea of relating the
activity of a molecule to the spatial distribution of a
number of functional groups (11) has been widely used
in QSAR (12) and structure-based studies as implemented
in programs like GRID (13), LigandScout (14) and
Catalyst (15).
The EDULISS database stores 3D atomic coordinates
for each molecule along with over 1600 calculated molecu-
lar properties. These so called molecular descriptors
provide a numerical proﬁle for each molecule consisting
of calculated values such as molecular weight, surface area
and number of rotatable bonds. By using a selection of
descriptors it is possible to rapidly select small related
families of molecules from the database. An extension of
this selection procedure provides a very efﬁcient way of
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range of interatomic distances between various atom types
for each molecule. The overall statistics of interatomic
distances is used in an ultrafast shape searching algorithm
(16). A speciﬁc subset of interatomic distances between all
hydrogen bond donor and acceptor atoms, halogens,
phosphorous and sulphur atoms provide what we call
the Interatomic Pharmacophore Proﬁle (IPP). All such
distance information is stored for each molecule in
pre-calculated bit-strings which provide the basis of a
wide range of pharmacophore searching routines and
also in the identiﬁcation of similarly shaped molecules.
The EDULISS database is therefore a useful tool for
identifying commercially available molecules based on
similarity or pharmacophore searches. It is distinguished
from other web resources by having over 1600 descriptors
for each compound and the ability to carry out unique 3D
and 2D searches. There are also convenient links for a
subset of compounds to the PubChem database allowing
easy access to biological data.
PROGRAM AND DATABASE DESCRIPTION
Database description
Currently, EDULISS stores over 5.5 million (over
4 million unique) compounds in total, containing data
from 28 different commercial and other smaller specialist
compound catalogues (Supplementary Data S1). 2D and
3D coordinates for each molecule are stored with over
1600 topological, geometrical, physicochemical and
toxicological descriptors per compound. In this
database, over 3.9 million compounds ﬁt the Lipinski’s
rule of ﬁve (17) and a total of 3.4 million ﬁt the Oprea
lead-like criteria (18): that is molecular weight 460,
number of rotatable bonds 10, calculated Log
P between 4 and 4.2, number of hydrogen bond accept-
ors 9, number of hydrogen bond donors 5 and number
of rings 4. The database also contains over 520000
compounds with molecular weight <250Da and potential-
ly ﬁtting the needs of fragment-based screening (19).
The biological properties of a subset of 291000
compounds stored in EDULISS has been retrieved from
four other databases, including PubChem, BindingDB
(20), ChemBank (21) and DrugBank (22), by identifying
identical molecules using the Maximum Common
Subgraph algorithm (23). The identity of these
compounds in the external databases has been obtained
and stored in the EDULISS database. A direct link
between EDULISS and the external database has been
implemented on the search result pages. Once a particular
compound which is identical to one of the PubChem com-
pounds has been hit by either 3D/2D similarity or
molecule ID search, the link in the ‘Chemical Properties’
box can lead users to the appropriate PubChem web page.
Certain catalogues (e.g. the National Cancer Institute)
contain many compounds for which there are a lot of
biological data and most hits will have links to the
relevant PubChem bioassay summary page.
The EDULISS database is held in a MySQL server.
The web-based interface of EDULISS uses Java Servlet
technology (see http://java.sun.com/products/servlet/) and
JavaServer Pages (JSP, see http://java.sun.com/products/
jsp/) to build the web pages (Figure 1). The web site
utilizes Apache Tomcat as the web server and the
runtime environment for Java technologies mentioned
above. For the molecule drawing and visualizing, JME
(http://www.molinspiration.com/jme/) and Jmol are
utilized which are applications written in Java providing
interactive features and have been included in the
EDULISS web pages. On the query result page, the
users can download the SDﬁle of hit compounds with
their descriptor values. To date, this database has been
used freely by the researchers from over 20 countries via
its web-based interface.
Treatment of compound structure data ﬁles, SDﬁles
Regardless of the source of catalogues, the compounds
used for EDULISS were entirely collected as 2D SDﬁle
formats then converted into 3D atomic coordinates using
CONCORD software. After the conversion process, the
molecules were processed by DRAGON 5.4 (http://www
.talete.mi.it/) and DEREK (http://www.lhasalimited.org)
software calculating 1664 physicochemical and potential
toxicity properties for each compound.
DATABASE APPLICATIONS
Recognition of unique compounds
As EDULISS holds millions of compounds from various
suppliers, it is useful to be able to determine the number of
unique compounds in the collection. A 2D graph theory
algorithm, Maximum Common Subgraph, MCS (23), has
been implemented. Although the MCS is able to precisely
identify isomorphous compounds, the number of pair-
wise comparisons increase as N(N1) where N is the
number of compounds and the run time grows
dramatically from 1h to 1day when the dataset increases
from 800 to 3200 compounds (Supplementary Data S2).
Thus, it is impossible to go through the whole EDULISS
collection using this method.
We have developed a method to efﬁciently identify
unique compounds by clustering according to speciﬁc
descriptor values (molecular properties). Using this
approach the required graphical comparisons can be
considerably decreased. Preliminary studies using molecu-
lar weight and atom type were not very useful as only 6%
of the compounds in EDULISS could be uniquely
identiﬁed. However a number of other molecular descrip-
tors show much better discrimination; W3D [Wiener 3D
index (24)], Whete [Wiener-type index from electronega-
tivity weighted distance matrix (25)] and Vu [a molecular
size descriptor which is one of the Weighted Holistic
Invariant Molecular descriptors (26)]. The combination
of these three descriptors alone was sufﬁcient to identify
3117625 unique compounds (out of a total of 4011697
unique compounds present in EDULISS). The remaining
2 million compounds were grouped using the three
descriptors (W3D, Whete and Vu) into 845193 clusters.
The compounds in these clusters with identical descriptors
were then compared using MCS. This procedure reduces
Nucleic AcidsResearch, 2011,Vol. 39, Database issue D1043Figure 1. The EDULISS web-based interface provides four search options, including descriptor-based searches, structure-based similarity searches,
IPP searches and search by molecule ID. On the query result pages, the users can download the SDﬁle of hit compounds with their descriptor values.
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down to 6495096 which can be carried out in 20h.
Similarity searching
EDULISS stores more than 1600 molecular descriptors
for each compound and users can select a series of descrip-
tor items as a query to identify a subset of molecules which
will share common properties. Molecular descriptors are
primarily organized into 20 groups according to their
attributes, so that the users can conveniently choose and
set preferred values for the query. For example it is a
simple matter to extract from the Sigma-Aldrich catalogue
the 164913 out of 199492 compounds that ﬁt the Lipinski
rule of ﬁve and the 142660 that comply with the Oprea
lead-like criteria.
EDULISS also provides geometrical similarity searches
based on a 3D similarity measurement called Ultra Fast
Shape Recognition with Atom Types (UFSRAT).
UFSRAT uses pre-generated geometric descriptors for
molecules within EDULISS to discriminate between
both the overall geometric, hydrophobic and electrostatic
shape of molecules.
Pharmacophore searching using EDULISS
The IPP for each molecule in the database consists of
interatomic distances calculated between 8 different
atom classes; namely hydrogen bond donor atoms
(HDon), hydrogen bond acceptor atoms (HAcc),
halogens (ﬂuorine, chlorine, bromine and iodine),
sulphur and phosphorus atoms. This gives rise to
15 possible types of interatomic distance for each
molecule. Distances are stored in strings 128 bits long as
Boolean values (1, true; 0, false). The ﬁrst bit represents a
distance less than or equal to 2.50A ˚ , the next bit is 0.25A ˚
longer (i.e. >2.50 and 2.75A ˚ ) and so forth until the last
bit which represents any distance >34.00A ˚ . Thus, there
are 15bit strings for each molecule representing the 15
types of possible distance pairs. Figure 2 illustrates the
Figure 2. Examples of the bit string composition of a virtual compound. Hydrogen bond acceptor (HAcc) atoms are coloured red and hydrogen
bond donor (HDon) atoms are coloured blue.
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HAcc and HDon.
This facility enables compounds to be identiﬁed that
have a speciﬁc geometric arrangement of atoms (‘pharma-
cophore’) as deﬁned by pair-wise distances of hydrogen
bond donors, acceptors, halogens, phosphorous or
sulphur atoms (where the searches are restricted to S
and P atoms that form double bonds to oxygen). For
pharmacaphore searching, a bit string is generated for
the user-deﬁned query distances which are then
compared to that of each compound in the database.
If a speciﬁc true bit in the query matches, the distance
criterion is met. A user can perform a multi-distance
query in a single search. Apart from very efﬁcient
storage, bit strings also provide a very fast searching
method as the necessary Boolean operations can be
carried out very quickly. Users can specify the query by
deﬁning preferred distances between selected atom types
using the web-based interface. The results are then
displayed and hits may be downloaded.
Case study 1: identifying cyclin dependent kinases
inhibitors. As a test for the pharmacaphore searching
routine we used the eight available structures of CDK
complexes stored in the PDBbind database (27) with
PDB codes 1AQ1, 1DI8, 1DM2, 1E1V, 1E1X, 1FVV,
1UNH and 2A4L. Three nitrogen atoms of the adenine
ring of ATP were used as a template to search for
ATP-analogues (Figure 3). Applying the three interatomic
distance criteria as shown in Figure 3b, four out of the
eight ligands (1DM2, 1E1V, 1E1X and 1UNH) were
identiﬁed as illustrated in Figure 3c–f, (The other four
ligands were not recognized as they do not have the
adenine-like pharmacophore)
Case study 2: identifying pyruvate kinase inhibitors. The
glycolytic enzyme pyruvate kinase (PYK) is a drug
target against trypanosomatid infection (28).
Fructose-2,6-bisphosphate (F-2,6-BP) acts as an allosteric
activator (29). We are interested in identifying analogue
molecules which interfere with allosteric regulation.
Figure 4a schematically shows selected interatomic
Figure 3. Schematic diagrams illustrating the CDK inhibitor pharmacaphore search. (a) the key interaction of ATP-binding pocket in the CDK2–
ATP complex (PDB id: 1HCK). (b) interatomic distances between the three atoms selected from the ATP adenine ring. The hydrogen bond donors
(HDon) and acceptors (HAcc) are coloured blue and red and labelled by residue name and ID. (c–f) show the interesting interactions of the four hit
CDK proteins whose ligand-bound interactions are similar to the pharmacaphore search model.
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three water molecules selected for pharmacophore
searches. Two example search motifs are shown in
Figure 4b and c. A series of tolerances have been given
for each interatomic distance from 10 to 25%. The
numbers of hit compounds in a range of tolerances are
tabulated in Figure 4. We selected eight compounds
(Sigma-Aldrich ID: N9002, L0144, P3504, 201332,
244813, D5021, H2516 and 86170) for further experimen-
tal assay based on visual inspection of the docked pose
Figure 4. Schematic diagrams of the relevant interactions of F-2,6-BP (FBP) in the effector site of PYK. (a) shows the interatomic distances between
ﬁve atoms in F-2,6-BP and three water molecules, selected for pharmacophore models. (b and c) Examples of pharmacaphore search models with
hydrogen bond donors (HDon) and acceptors (HAcc) coloured blue and red. Sulfonate (SO3) is coloured yellow. (d) illustrates the hit compound
P3504 in different orientations to show that both pharmacophore proﬁles ﬁt.
Nucleic AcidsResearch, 2011,Vol. 39, Database issue D1047and on calculated solubility. Of the eight selected com-
pounds, ﬁve signiﬁcantly affected the PYK enzyme
kinetics. Figure 4d shows that both pharmacophore
search models match atoms of the hit compound P3504
which showed 33% inhibition of enzyme activity. A
complex of P3504 with Leishmania mexicana PYK
(LmPYK) has been crystallized and solved at a resolution
of 2.7A ˚ (H. P. Morgan personal communication) showing
the molecule binds at the effector site.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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